Alba G. Alvarado Balderas’ Post

API manufacturing is facing unprecedented challenges and opportunities, from increasing regulatory scrutiny to rising costs and intensified competition, the industry is in a state of flux. Join the upcoming webinar with - Molly Bowman, Head of Strategy for Pharmaceutical SCM, Clarivate Analytics, Mike Ward, Head of Thought Leadership, Life Sciences, Clarivate Analytics, Alicia Xaka, Associate Director, Business Development, US & Canada, PROCOS S.P.A. (CBC Group) and Gunjan Singh, Head of Mature Markets API, Dr. Reddy's Laboratories - to explore the evolving landscape of API manufacturing, major industry changes in Chinese and Indian markets, navigating competitive pressures and more. Register here: https://lnkd.in/e-GBensb #RegulatoryCompliance #APIManufacturing #Pharma #Webinar #IndustryInsights

The changing dynamics of global API manufacturing - webinar imperdível para quem se preocupa com a cadeia de suprimentos global!

The LATAM pharmaceutical market is poised to become a prime destination for domestic and international pharma companies, for clinical trials and for investment in local manufacturing sites. Read a new whitepaper on overcoming the barriers to success faced by the LATAM pharmaceutical industry. #LATAM #pharmaceutical #API #supplychain #clinicaltrials

Our goal at Clarivate is to be the strategic partner to the industry, helping it as it makes some of the most strategic decisions. It was so exciting to see our LatAm team bring together the Life Sciences Industry, across Pharma and Chemical Manufacturers, as well as government and regulators to discuss how we can drive more innovation in Life Sciences in Latin America. Based on those discussions our team, with the help of our customers and partners, created this new whitepaper entitled, LATAM Summit: Navigating market and innovation opportunities. From market development to establishing public policies in LATAM markets, the report discusses how the independence of API imports, internationalization and incremental innovation can impact transformation in the region and shape the future.   Read more on how harmonizing efforts of industry, government and academia can drive effective change, success and innovation in LATAM, here: https://lnkd.in/eg34EyFh   #LATAM #pharma #API #clinicaltrials #innovation

The term "involution", in Chinese "内卷", has become increasingly popular in recent years, describing a phenomenon where individuals or organizations intensify competition without an increase in resources, ultimately leading to a decline in overall efficiency. This concept is particularly evident in the price wars within the pharmaceutical industry (API and intermediates). As the market becomes saturated and costs continue to rise, many pharmaceutical companies find themselves stuck in a vicious cycle of price competition. In the race to capture market share, companies continuously lower their prices, squeezing profit margins and often underinvesting in research and innovation. While it may seem that companies are surviving the competition, they are actually trapped in an "involution" dilemma: market saturation, thin profits, and hindered long-term growth for the entire industry. So, how can we break free from this situation? I believe the following points are crucial: Differentiated Innovation: Invest in the development of new products, technologies or improve existing products to enhance their uniqueness and avoid pure price competition. Collaborative Success: Strengthen partnerships within and beyond the industry through joint research and resource sharing, achieving cost-sharing and maximizing benefits. Focus on Value: Pay attention to the real needs of customers by offering products and services with higher added value, thereby increasing market competitiveness. In this era of involution, only through innovation and collaboration can we break the vicious cycle of price wars and achieve healthy development in the pharmaceutical industry. Feel free to share your thoughts and comments.

An excellent report @Expert Group on Future Skills Needs (EGFSN) forecasting the current and future skills needs of the Biopharma sector in Ireland to 2027 #regionalskills #training #skillsforlife ##Biopharma Read the report including key recommendations here https://lnkd.in/eaHR225n

Pharma production is forecast to experience healthy growth over the coming years 🧪📈 The main growth drivers are aging populations, emerging markets demand and new products, but some concerns around profitability exist 🤔 In the US and Europe, governments are pushing back against high drug costs with new pricing policies, which could limit revenues and lower incentives to invest in R&D. In emerging markets, quality standard issues remain a downside risk. Read about the latest developments and trends in the industry provided by our pharmaceutical sector experts 👉 https://brnw.ch/21wMw8p ✍️ Judy Ji ✍️ Rubén Del Río Hernández ✍️ Brady McKinney ✍️ Christian Bürger #pharmaceuticals #pharmaindustry #pharmaoutlook #pharceuticalsindustry #pharceuticalsoutlook

🌟 Science Exchange is proud to be at the forefront of transforming R&D processes in the Pharmaceutical & Life Sciences (PLS) industry.  🧪💼 In this article, we're excited to see the spotlight on transitioning from traditional operations to tech-enabled, efficient processes. It aligns perfectly with our core mission and the impact we're making on the #PLS industry. 🚀 We harness technology and strategic cost management to redefine how R&D organizations work with suppliers. Leading #pharmaceutical companies, #biotechs, and #academics have embraced our #supplierorchestration platform, enabling them to streamline and optimize their research and development processes. The result? Faster, more accurate, and highly efficient operations. 💡 Our platform offers streamlined #projectmanagement and #procurement processes, reducing the time and resources spent on administrative tasks. This allows researchers to dedicate more effort to their core scientific work, driving #scientificdiscovery at an accelerated pace. We’re inspired to see thought leaders like PwC recognizing the immense potential within R&D for executives to cut costs without compromising their mission or critical capabilities. ✨ #NextGenGBS #ResearchandDevelopment #PharmaIndustry #LifeSciences #Technology

📈 Many pharmaceutical and life science companies are now taking a fresh look at their operating models. Next-Gen Global Business Services (GBS) can play a bigger role in how these companies reinvent work across the value chain. Discover how this innovative approach can help drive advanced business outcomes at lower costs and faster speeds. Very proud of the work our team is doing to support clients on this journey. #PharmaIndustry #NextGenGBS #Innovation